drugset / Trial / NCT02136342

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

NCT02136342

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.

Timeline

Start
2014-05
Primary completion
2015-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorogenic acid Small molecule

Indications

No indication recorded.